TherapeuticsMD (TXMD) Share-based Compensation Growth (1y) (2011 - 2026)
Powered by 
Analysis
TherapeuticsMD (TXMD) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | -119.48% |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | -7.26% |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 37.96% |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 22.66% |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | -1.46% |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | - |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | -8.89% |
| 10 | TherapeuticsMD | 25.35 Mn | 16.16 Mn | - | 256,047.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 256,047.36% |
| Mar 31, 2026 | 83.84% |
| Dec 31, 2025 | -1,005.36% |
| Sep 30, 2025 | -17.69% |
| Jun 30, 2025 | -46.84% |
| Mar 31, 2025 | 109.10% |
| Dec 31, 2024 | -102.28% |
| Sep 30, 2024 | -73.39% |
| Jun 30, 2024 | -78.03% |
| Mar 31, 2024 | -230.23% |
| Dec 31, 2023 | 123.27% |
| Sep 30, 2023 | -96.18% |
| Jun 30, 2023 | -96.42% |
| Mar 31, 2023 | -76.56% |
| Dec 31, 2022 | -79.34% |
| Sep 30, 2022 | -66.87% |
| Jun 30, 2022 | -47.99% |
| Mar 31, 2022 | 4,022.00% |
| Dec 31, 2021 | 142.27% |
| Sep 30, 2021 | -22.94% |